Archives of Neuroscience

Published by: Kowsar

Intravenous Thrombolysis for Stroke in Patients Receiving Oral Factor Xa Inhibitors

Ashkan Mowla 1 , * , Navdeep S. Lail 1 , Caila B. Vaughn 1 , Haris Kamal 1 , Robert N. Sawyer 1 and Christopher Deline 1
Authors Information
1 Stroke Division, Department of Neurology, The State University of New York at Buffalo, Buffalo, United States
Article information
  • Archives of Neuroscience: October 2018, 5 (4); e67359
  • Published Online: July 28, 2018
  • Article Type: Brief Report
  • Received: February 11, 2018
  • Revised: July 12, 2018
  • Accepted: July 25, 2018
  • DOI: 10.5812/ans.67359

To Cite: Mowla A, Lail N S, Vaughn C B, Kamal H, Sawyer R N, et al. Intravenous Thrombolysis for Stroke in Patients Receiving Oral Factor Xa Inhibitors, Arch Neurosci. 2018 ; 5(4):e67359. doi: 10.5812/ans.67359.

Abstract
Copyright © 2018, Archives of Neuroscience. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Discussion
Acknowledgements
References
  • 1. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-236. doi: 10.1161/STR.0000000000000024. [PubMed: 24788967].
  • 2. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947. doi: 10.1161/STR.0b013e318284056a. [PubMed: 23370205].
  • 3. Mowla A, Singh K, Mehla S, Ahmed MK, Shirani P, Kamal H, et al. Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm? Int J Stroke. 2015;10 Suppl A100:113-8. doi: 10.1111/ijs.12616. [PubMed: 26377963].
  • 4. Mowla A, Shah H, S. Lail N, Shirani P. Successful Intravenous Thrombolysis for Acute Stroke Caused by Polycythemia Vera. Arch Neurosci. 2017;4(4). e62181. doi: 10.5812/archneurosci.62181.
  • 5. Mowla A, Singh Lail N, Singh K, Mehla S, Shirani P. Safety of Intravenous Thrombolysis for Stroke in a Patient With Multiple Intracranial Neoplasm. Arch Neurosci. 2016;3(2). e60046. doi: 10.5812/archneurosci.32958.
  • 6. Mowla A, S. Lail N, Shirani P. Acute Pancreatitis in the Setting of Acute Ischemic Stroke. Arch Neurosci. 2017;4(2). e42957. doi: 10.5812/archneurosci.42957.
  • 7. Singh K, Mowla A, Mehla S, Ahmed MK, Shirani P, Zimmer WE, et al. Safety of intravenous thrombolysis for acute ischemic stroke in patients with preexisting intracranial neoplasms: a case series. Int J Stroke. 2015;10(3):E29-30. doi: 10.1111/ijs.12455. [PubMed: 25777837].
  • 8. Shahjouei S, Tsivgoulis G, Bavarsad Shahripour R, Jones GM, Alexandrov AV, Zand R. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases. J Stroke Cerebrovasc Dis. 2015;24(12):2685-93. doi: 10.1016/j.jstrokecerebrovasdis.2015.07.021. [PubMed: 26542821].
  • 9. Fluri F, Fleischer M, Kleinschnitz C. Accidental Thrombolysis in a Stroke Patient Receiving Apixaban. Cerebrovasc Dis Extra. 2015;5(2):55-6. doi: 10.1159/000375181. [PubMed: 26120321]. [PubMed Central: PMC4464016].
  • 10. Cappellari M, Bovi P. Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update. Thromb Haemost. 2015;114(2):440-4. doi: 10.1160/TH14-11-0973. [PubMed: 25809649].
  • 11. De Smedt A, Cambron M, Nieboer K, Moens M, Van Hooff RJ, Yperzeele L, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with apixaban. Int J Stroke. 2014;9(7). E31. doi: 10.1111/ijs.12315. [PubMed: 25231581].
  • 12. Korya D, Dababneh H, Moussavi M, Panezai S, Noor E, Kirmani JF. Intravenous thrombolysis in a patient using factor Xa inhibitor. J Vasc Interv Neurol. 2014;7(3):1-4. [PubMed: 25298850]. [PubMed Central: PMC4188256].
  • 13. Kimura S, Ogata T, Fukae J, Okawa M, Higashi T, Iwaasa M, et al. Revascularization for acute ischemic stroke is safe for rivaroxaban users. J Stroke Cerebrovasc Dis. 2014;23(9):e427-31. doi: 10.1016/j.jstrokecerebrovasdis.2014.05.015. [PubMed: 25149204].
  • 14. Neal AJ, Campbell BC, Chandratheva A, Hand PJ, Davis SM. Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use. J Clin Neurosci. 2014;21(11):2013-5. doi: 10.1016/j.jocn.2014.03.029. [PubMed: 24984844].
  • 15. Ishihara H, Torii H, Imoto H, Oka F, Sadahiro H, Suzuki M. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban. J Stroke Cerebrovasc Dis. 2014;23(10):e457-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.008. [PubMed: 25280819].
  • 16. Bornkamm K, Harloff A. Safe intravenous thrombolysis in acute stroke despite treatment with rivaroxaban. J Clin Neurosci. 2014;21(11):2012-3. doi: 10.1016/j.jocn.2014.03.017. [PubMed: 24938385].
  • 17. van Hooff RJ, Nieboer K, De Smedt A, Yperzeele L, Jochmans K, De Keyser J, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban. Clin Neurol Neurosurg. 2014;122:133-4. doi: 10.1016/j.clineuro.2013.12.029. [PubMed: 24813326].
  • 18. Seiffge DJ, Traenka C, Gensicke H, Tsakiris DA, Bonati LH, Peters N, et al. Intravenous thrombolysis in stroke patients receiving rivaroxaban. Eur J Neurol. 2014;21(1):e3-4. doi: 10.1111/ene.12285. [PubMed: 25133279].
  • 19. Kawiorski MM, Alonso-Canovas A, de Felipe Mimbrera A, Sainz de la Maza S, Alvarez-Velasco R, Zarza B, et al. Successful intravenous thrombolysis in acute ischaemic stroke in a patient on rivaroxaban treatment. Thromb Haemost. 2014;111(3):557-8. doi: 10.1160/TH13-06-0472. [PubMed: 24196421].
  • 20. Fluri F, Heinen F, Kleinschnitz C. Intravenous thrombolysis in a stroke patient receiving rivaroxaban. Cerebrovasc Dis Extra. 2013;3(1):153-5. doi: 10.1159/000355839. [PubMed: 24348499]. [PubMed Central: PMC3843901].
  • 21. Steiner T, Bohm M, Dichgans M, Diener HC, Ell C, Endres M, et al. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol. 2013;102(6):399-412. doi: 10.1007/s00392-013-0560-7. [PubMed: 23669868].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments